In Vitro Fertilization Banking Services Market Worth US$ 9.1 Billion by 2031 – Growth Plus Reports


Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) — The market analysis of the global in vitro fertilization banking services market was conducted by Growth Plus Reports in 2022 and is valued at US$ 3.8 billion. The market is expected to hit a revenue CAGR of 9.80% to reach US$ 9.1 billion by 2031.

Analysis of the global market for in vitro fertilization banking services indicates that the revenue share is likely to increase significantly during the forecast period. IVF banking services include the collection, freezing, and storage of embryos, oocytes, and sperm for future IVF treatments.

Key Takeaways: 


  • The rising adoption of IVF as a viable option is driving the market revenue share.
  • The growing tendency of deferring childbearing until later in life, particularly in affluent nations, is increasing demand for in vitro fertilization banking services.
  • According to Yalemedicine forecasts for 2023, around 15% of couples in the United States are having problems conceiving, with male infertility affecting more than 50% of the time.

Request a Free Sample PDF:

             In Vitro Fertilization Banking Services Market Scope

Report Attribute Details
Market Size Value in 2022 US$ 3.8 billion
Revenue Forecast in 2031 US$ 9.1 billion
CAGR 9.80%
Base Year for Estimation 2022
Forecast Period 2023 to 2031
Historical Year 2021
Segments Covered Service Type and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Recent Development in the In Vitro Fertilization Banking Services Market: 

  • In February 2023, California Cryobank, a new donor sperm bank for the Canadian market, was founded in Canada by Generate Life Sciences.

Competitive Landscape

A list of the companies operating in the global in vitro fertilization banking services market includes: 

  • Seattle Sperm Bank
  • Cryos International
  • European Sperm Bank
  • CCRM’s network
  • Boston IVF’s network

Market Drivers and Restraints: 

The market revenue for in vitro fertilization banking services is driven by the rising cases of infertility among couples, planning parenthood in their later life, awareness of IVF, technological advancements, and high disposable incomes. 

However, due to the high expenses, the in vitro fertilization banking services market revenue growth will likely be restrained. 

Market Segmentation: 

  • Based on service type, the global in vitro fertilization banking services market is segmented into egg banking and sperm banking. 
  • The egg banking segment is further sub-segmented into fresh donor egg cycle and frozen donor egg cycle.                 
  • The sperm banking segment is further sub-segmented into sperm storage services and andrology services.        

Request for Customization –

Segmentation By Service Type

Based on the service type, the sperm banking segment dominates the global in vitro fertilization banking services market with the largest revenue share. This large revenue share is attributed to increased demand for sperm preservation and donation services. Furthermore, increased fertility treatment knowledge and the rising frequency of male infertility are boosting the demand for in vitro fertilization banking services.

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global in vitro fertilization banking services market. In North America, many couples are choosing in vitro fertilization procedures. Furthermore, rising infertility rates and supportive government policies raise awareness of fertility preservation. 

Report Coverage 

Growth Plus Reports carried out extensive market research on the in vitro fertilization banking services market globally. We examined the fundamental market characteristics, significant investment opportunities, regional growth patterns, ten-year revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
    4. Reimbursement Scenario 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities


Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst:

Visit our report store at –

Browse more latest healthcare reports:

Anticholesteremic Agents Market by Drug Class (Bile Acid Resins, Statins), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Glucose Elevating Agents Market by Products (Glucagon, Diazoxide), Indication (Hypoglycemia, Insulinoma), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), – Global Outlook & Forecast 2023-2031

Expat Health Insurance Market by Service Provider (Private, Public), Indication (Emergency Medical Evacuation, Maternity Coverage, Outpatient Coverage), Term Plan (Short-Term, Long-Term) – Global Outlook & Forecast 2023-2031

Veterinary Euthanasia Drugs Market by Animal Type (Companion Animals and Farm Animals), Route of Administration (Injectable Euthanasia Drugs, Inhalational Euthanasia Drugs) – Global Outlook & Forecast 2023-2031

MISME Syndrome Market by Treatment (Surgery, Radiotherapy, Pharmacotherapy) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.